FDA accepts Sandoz regulatory submission for a generic version of Advair Diskus®

  • FDA accepts Sandoz ANDA for substitutable generic version of Advair Diskus®
  • Sandoz believes its combination product will offer asthma and COPD patients same safety and efficacy as reference medicine
  • Sandoz looks forward to working with FDA to drive access to this treatment option

Holzkirchen, June 15, 2017- Sandoz today announced that the US Food and Drug Administration (FDA) has accepted its Abbreviated New Drug Application for fluticasone propionate / salmeterol combination product, a substitutable …

/by

FDA accepts Sandoz regulatory submission for a generic version of Advair Diskus®

  • FDA accepts Sandoz ANDA for substitutable generic version of Advair Diskus®
  • Sandoz believes its combination product will offer asthma and COPD patients same safety and efficacy as reference medicine
  • Sandoz looks forward to working with FDA to drive access to this treatment option

Holzkirchen, June 15, 2017- Sandoz today announced that the US Food and Drug Administration (FDA) has accepted its Abbreviated New Drug Application for fluticasone propionate / salmeterol combination product, a substitutable …

/by